Haakensen VD, Öjlert ÅK, Thunold S, Farooqi S, Nowak AK, Chin WL, Grundberg O, Szejniuk WM, Cedres S, Sørensen JB, Dalen TS, Lund-Iversen M, Bjaanæs M, Helland Å(2024) UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial Eur J Cancer, 202, 113973 DOI 10.1016/j.ejca.2024.113973, PubMed 38447379
Gullhaug A, Haakensen VD, De Ruysscher D, Simone CB, Hotca-Cho AE, Chhabra AM, Hellebust TP, Paulsen EE, Dimopoulos MP, Johansen S(2024) Lung cancer reirradiation: Exploring modifications to utilization, treatment modalities and factors associated with outcomes J Med Imaging Radiat Sci(in press) DOI 10.1016/j.jmir.2024.02.004, PubMed 38429174
Langberg CW, Horndalsveen H, Helland Å, Haakensen VD(2023) Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC Front Oncol, 13, 1217424 DOI 10.3389/fonc.2023.1217424, PubMed 37476372